Indegene has been honored with the 2026 Global Enabling Technology Leadership Recognition by Frost & Sullivan for its AI-powered pharmaceutical commercialization services. The award acknowledges Indegene’s expertise in combining domain-led AI, knowledge orchestration, and integrated execution to transform commercialization workflows, driving significant value for pharmaceutical organizations.
Indegene Honored for AI Innovation
Indegene has been recognized with the 2026 Global Enabling Technology Leadership Recognition from Frost & Sullivan, a testament to its pioneering work in AI-powered pharmaceutical commercialization. This prestigious award highlights Indegene’s success in integrating domain-led Artificial Intelligence, sophisticated knowledge orchestration, and end-to-end execution capabilities to revolutionize commercialization workflows within the pharmaceutical sector.
Excellence in Pharma Commercialization
The recognition specifically commends Indegene for its outstanding achievements in AI-powered commercialization, workflow transformation, and the creation of customer value. Frost & Sullivan’s evaluation focused on Indegene’s ability to align its AI strategy with the evolving demands of the pharmaceutical industry, demonstrating excellence in both strategy effectiveness and execution across various critical workflows such as commercial, medical, and regulatory.
Innovative Pharma Operating System
Indegene’s approach redefines pharmaceutical commercialization by uniting model-agnostic technology with deep life sciences expertise. Its Pharma Operating System (OS) is designed to connect business decisions, workflow execution, and intelligence enterprise-wide, enabling organizations to replace fragmented processes with integrated and adaptive operating models. The company’s Cortex reasoning engine further enhances this by codifying specialized knowledge and guiding AI-enabled workflows.
Driving Value Through Intelligence and Execution
Vivek Ghai, EVP, Enterprise Commercial Solutions at Indegene, stated that the company’s focus is on embedding AI into organizational operations to drive smarter decisions, faster execution, and measurable business outcomes. This award underscores Indegene’s commitment to helping life sciences companies build sustainable competitive advantages in an increasingly AI-driven market.
Source: BSE
